Disease | hepatitis c |
Phenotype | C0021053|immune disease |
Sentences | 3 |
PubMedID- 25195983 | Before determining the safety of anti-tnf drugs in the treatment of autoimmune diseases in patients with hepatitis c infection, studies with large homogeneous patient groups must be performed, and the exact group of hepatitis c virus infected patients for whom anti-tnf treatment would be deemed safe should be identified. |
PubMedID- 23439301 | Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis c. |
PubMedID- 21131699 | Autoimmune diseases co-existing with hepatitis c virus infection. |
Page: 1